European Hematology Association Congress

Maintenance Darzalex Regimen Promising in Post-Transplant Myeloma

June 10th 2023, 6:00pm

Article

Maintenance Darzalex, with or without Pomalyst was safe and efficacious in treating patients with relapsed myeloma who underwent salvage autologous hematopoietic stem cell transplant.

Iclusig With Chemo ‘Should Be Standard of Care’ for ALL Subset

June 10th 2023, 3:00pm

Article

Iclusig plus reduced-intensity chemotherapy led to improved outcomes for patients with Philadelphia chromosome (Ph)–positive acute lymphoblastic leukemia, and should be the new standard of care, one expert said.

Study Examines Calquence in Older CLL Population

June 9th 2023, 9:00pm

Article

An ongoing trial is examining Calquence in older or frail patients with chronic lymphocytic leukemia — a group that is typically left out of clinical trials.